Literature DB >> 3156560

Tissue and blood T-lymphocyte subpopulations in erythema nodosum leprosum.

R L Modlin, A C Bakke, S A Vaccaro, D A Horwitz, C R Taylor, T H Rea.   

Abstract

To study T lymphocytes in erythema nodosum leprosum (ENL), monoclonal antibodies were used to identify T-lymphocyte subpopulations in the blood and skin lesions of patients with ENL and patients with nonreactional lepromatous leprosy. The blood of nonreactional lepromatous patients had a lymphopenia and a proportionate reduction in pan T cells, helper-inducer, and suppressor-cytotoxic subsets, but a normal helper-suppressor ratio, as compared with controls. Patients with ENL did not differ significantly from the controls. In skin lesions, an admixture of helper and suppressor phenotypes among foamy histiocytes was found. The ENL tissue had more numerous cells of the helper-inducer phenotype and fewer of the suppressor-cytotoxic phenotype, as compared with nonreaction lepromatous tissues. In 22 patients with simultaneous examination of tissue and blood T-cell subsets, there was no correlation between tissue and blood helper-suppressor ratios, indicating that some sort of selection process brings lymphocytes into tissues from peripheral blood.

Entities:  

Mesh:

Year:  1985        PMID: 3156560

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  11 in total

Review 1.  T cell and cytokine patterns in leprosy skin lesions.

Authors:  P A Sieling; R L Modlin
Journal:  Springer Semin Immunopathol       Date:  1992

Review 2.  Immunopathology of leprosy granulomas.

Authors:  R L Modlin; T H Rea
Journal:  Springer Semin Immunopathol       Date:  1988

3.  Serum lymphocytotoxic activity in leprosy.

Authors:  F N Rasheed; M Locniskar; D J McCloskey; R S Hasan; T J Chiang; P Rose; R de Soldenhoff; H Festenstein; K P McAdam
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

4.  In situ characterization of T lymphocyte subpopulations in leprosy in the mangabey monkey.

Authors:  R L Modlin; L D Ormerod; G P Walsh; T H Rea; W M Meyers; C H Binford; L N Martin; R H Wolf; B J Gormus
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

5.  Lepromatous leprosy with erythema nodosum leprosum as immune reconstitution inflammatory syndrome in an HIV-1 infected patient after initiation of antiretroviral therapy.

Authors:  Alexia Cusini; Huldrych F Günthard; Rainer Weber; Milo Huber; Jivko Kamarashev; Barbara Bertisch; Silke Peter; Bernhard Beck
Journal:  BMJ Case Rep       Date:  2009-12-01

6.  Involvement of TNF-Producing CD8+ Effector Memory T Cells with Immunopathogenesis of Erythema Nodosum Leprosum in Leprosy Patients.

Authors:  Pedro Henrique L Silva; Luciana N Santos; Mayara A Mendes; José A C Nery; Euzenir N Sarno; Danuza Esquenazi
Journal:  Am J Trop Med Hyg       Date:  2019-02       Impact factor: 2.345

7.  Expression of adhesion molecules in leprosy lesions.

Authors:  L Sullivan; S Sano; C Pirmez; P Salgame; C Mueller; F Hofman; K Uyemura; T H Rea; B R Bloom; R L Modlin
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

8.  Cell-type deconvolution with immune pathways identifies gene networks of host defense and immunopathology in leprosy.

Authors:  Megan S Inkeles; Rosane Mb Teles; Delila Pouldar; Priscila R Andrade; Cressida A Madigan; David Lopez; Mike Ambrose; Mahdad Noursadeghi; Euzenir N Sarno; Thomas H Rea; Maria T Ochoa; M Luisa Iruela-Arispe; William R Swindell; Tom Hm Ottenhoff; Annemieke Geluk; Barry R Bloom; Matteo Pellegrini; Robert L Modlin
Journal:  JCI Insight       Date:  2016-09-22

9.  Evidence that the Mitsuda reaction to Mycobacterium leprae can be mediated by lymphocytes responsive to Mycobacterium tuberculosis.

Authors:  P P Roberts; H M Dockrell; K P McAdam
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

10.  Analysis of naturally occurring delayed-type hypersensitivity reactions in leprosy by in situ hybridization.

Authors:  C L Cooper; C Mueller; T A Sinchaisri; C Pirmez; J Chan; G Kaplan; S M Young; I L Weissman; B R Bloom; T H Rea; R L Modlin
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.